SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-022388
Filing Date
2023-08-08
Accepted
2023-08-08 07:00:11
Documents
15
Period of Report
2023-08-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20230807_8k.htm   iXBRL 8-K 24822
2 EXHIBIT 99.1 ex_555936.htm EX-99.1 12060
7 monoparlogordg.jpg GRAPHIC 7912
  Complete submission text file 0001437749-23-022388.txt   191296

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20230808.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20230808_def.xml EX-101.DEF 12186
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20230808_lab.xml EX-101.LAB 16395
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20230808_pre.xml EX-101.PRE 12456
9 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20230807_8k_htm.xml XML 2757
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 231149227
SIC: 2834 Pharmaceutical Preparations